Author(s):
A.K. Sadanov, I.R. Kulmagambetov, F.N. Nurmanbetova, G. Zh. Sarsenbayeva, I.A. Ratnikova, S.Orazymbet, Ye.Zh. Shorabayev, B.B. Baimakhanova, L.Ye. Protasyuk, A.D. Massirbayeva
Email(s):
irina.ratn@gmail.com
DOI:
10.52711/0974-360X.2024.00613
Address:
A.K. Sadanov1, I.R. Kulmagambetov2, F.N. Nurmanbetova2, G. Zh. Sarsenbayeva2, I.A. Ratnikova2, S.Orazymbet2, Ye.Zh. Shorabayev2, B.B. Baimakhanova1, L.Ye. Protasyuk1, A.D. Massirbayeva2
1Scientific and Production Center of Microbiology and Virology LLP, Almaty, Kazakhstan.
2Industrial Microbiology LLP, Almaty, Kazakhstan.
*Corresponding Author
Published In:
Volume - 17,
Issue - 8,
Year - 2024
ABSTRACT:
The effectiveness of probiotic medications in the treatment of infectious diseases of the gastrointestinal tract has been proven in many clinical studies. Despite this, currently, some preparations do not have the appropriate quality and activity against pathogenic microorganisms. The reason for this is the lack of a stage for the selection of antagonists to specific pathogens at the stage of research and medication development. Given the high prevalence of intestinal infections among the population of Kazakhstan and the lack of made-in-Kazakhstan probiotic medications in the pharmaceutical market, there is a need to introduce an effective preparation based on probiotic microorganisms for the treatment of infectious diseases of the gastrointestinal tract. The purpose of this study was to demonstrate the methodology and results of the first phase of clinical trials of this preparation. The study was conducted following the ethical principles of the Helsinki Declaration, the Order of the Acting Minister of Health of the Republic of Kazakhstan, the Order of the Minister of Health of the Republic of Kazakhstan, and the Code of the Republic of Kazakhstan. 20 healthy volunteers of both sexes aged 18 to 50 years with a verified state of health, who had given informed consent, were examined before the start of the study, and the results of clinical measurement of the initial condition were also obtained, which was then compared with daily measurements during the use of the preparation under study and a week after the last administration. As a result of the study, it was concluded that the preparation was well-tolerated without noticeable side effects, which indicates the safety of the medication.
Cite this article:
A.K. Sadanov, I.R. Kulmagambetov, F.N. Nurmanbetova, G. Zh. Sarsenbayeva, I.A. Ratnikova, S.Orazymbet, Ye.Zh. Shorabayev, B.B. Baimakhanova, L.Ye. Protasyuk, A.D. Massirbayeva. First Phase of the Clinical trial of the AS-Probionorm Probiotic Medication for the treatment of Human Intestinal Infections. 2024; 17(8):39498-4. doi: 10.52711/0974-360X.2024.00613
Cite(Electronic):
A.K. Sadanov, I.R. Kulmagambetov, F.N. Nurmanbetova, G. Zh. Sarsenbayeva, I.A. Ratnikova, S.Orazymbet, Ye.Zh. Shorabayev, B.B. Baimakhanova, L.Ye. Protasyuk, A.D. Massirbayeva. First Phase of the Clinical trial of the AS-Probionorm Probiotic Medication for the treatment of Human Intestinal Infections. 2024; 17(8):39498-4. doi: 10.52711/0974-360X.2024.00613 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2024-17-8-61
REFERENCES:
1. Shalini S. Sujata D. Evaluation of Market Curd for Sanitary Quality and Bacteriocin-Producing Lactic acid Bacteria for Potential Application as a Natural, Healthy Food Preservative. Research Journal of Pharmacy and Technology. 2017; 10(4): 1029-1033. https://doi.org/10.5958/0974-360X.2017.00186.X
2. Maanickha CKS. Karthik NS. Kanagarajan A. Insomnia Management Clinical Trials by various Conventional Therapies – A Review. Research Journal of Pharmacy and Technology. 2023; 16(12): 6071-6076. https://doi.org/10.52711/0974-360X.2023.00985
3. Corr SC. Hill C. Gahan CGM. Understanding the Mechanisms by Which Probiotics Inhibit Gastrointestinal Pathogens. Advances in Food and Nutrition Research. 2009; 56: 1–15. https://doi.org/10.1016/s1043-4526(08)00601-3
4. Krishna RR. Samak G. Protection and Restitution of Gut Barrier by Probiotics: Nutritional and Clinical Implications. Current Nutrition and Food Science. 2013; 9(2): 99–107. https://doi.org/10.2174/1573401311309020004
5. Wells JM. Immunomodulatory mechanisms of lactobacilli. Microbial Cell Factories. 2011; 10(S1): 1-15. https://doi.org/10.1186%2F1475-2859-10-S1-S17
6. Anbarasu S. Kumar V. Revathy K. Govindaraju K. Biogenic production of Gold nanoparticles using Lactic acid bacteria and their Anti-mycobacterial activity. Research Journal of Pharmacy and Technology. 2020; 13(9): 4391-4394. http://dx.doi.org/10.5958/0974-360X.2020.00776.3
7. Nikolaeva SV. Zolotarev YuV. Gorelov AV. Primenenie probiotikov v meditsinskoi praktike [The use of probiotics in medical practice]. RMZh. Meditsinskoe Obozrenie. 2018; 8(11): 84–87.
8. do Carmo MS. Santos CID. Araújo MC. Girón JA. Fernandes ES. Monteiro-Neto V. Probiotics, mechanisms of action, and clinical perspectives for diarrhea management in children. Food and Function. 2018; 9(10): 5074-5095. https://doi.org/10.1039/c8fo00376a
9. Gut AM. Vasiljevic T. Yeager T. Donkor ON. The effectiveness of dry probiotic in the treatment and prevention of salmonellosis. International Journal of Pharmaceutical Research. 2018; 10(4): 626-631. https://doi.org/10.1099/mic.0.000709
10. Oleinikova Y. Badryzlova N. Alybayeva A. Yermekbay Z. Amangeldi A. Sadanov AMA. Effect of a probiotic preparation based on lactic and propionic acid bacteria on the growth of young rainbow trout Oncorhynchus mykiss in aquaculture. International Journal of Veterinary Science 2024; 13(3): 319-327. https://doi.org/10.47278/journal.ijvs/2023.107.
11. Łukasik J. Guo Q. Boulos L. Szajewska H. Johnston BC. Probiotics for the prevention of antibiotic-associated adverse events in children—A scoping review to inform development of a core outcome set. PLoS One. 2020; May 29; 15(5): e0228824. https://doi.org/10.1371/journal.pone.0228824
12. Ma Y. Yang JY. Peng X. Xiao KY. Xu Q. Wang C. Which probiotic has the best effect on preventing Clostridium difficile‐associated diarrhea? A systematic review and network meta‐analysis. Journal of Digestive Diseases. 2020; 21(2): 69-80. https://doi.org/10.1111/1751-2980.12839
13. McFarland LV. Goh S. Are probiotics and prebiotics effective in the prevention of travellers’ diarrhea: a systematic review and meta-analysis. Travel Medicine and Infectious Disease. 2019 Jan-Feb; 27: 11-19. https://doi.org/10.1016/j.tmaid.2018.09.007
14. Shi X. Zhang J. Mo L. Shi J. Qin M. Huang X. Efficacy and safety of probiotics in eradicating Helicobacter pylori: A network meta-analysis. Medicine. 2019; 98(15): e15180. https://doi.org/10.1097/md.0000000000015180
15. Dewi NP. Poddar S. Rai RP. Purwati E. Dessy A. Pratama YE. The Potential Lactic Acid Bacteria from Dadiah Sianok Bukittinggi City, West Sumatera as Probiotic. Research Journal of Pharmacy and Technology. 2023; 16(2): 627-634. https://doi.org/10.52711/0974-360X.2023.00107
16. Alfaleh K. and Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Evidence-Based Child Health. 2014; 9(3): 584–671. https://doi.org/10.1002/ebch.1976
17. Underwood MA. Probiotics and the prevention of necrotizing enterocolitis. Journal of Pediatric Surgery. 2019; 54(3): 405–412. https://doi.org/10.1016/j.jpedsurg.2018.08.055
18. Hudson LE. Anderson SE. Corbett AH. Lamb TJ. Gleaning insights from fecal microbiota transplantation and probiotic studies for the rational design of combination microbial therapies. Clinical Microbiology Reviews. 2017; 30(1): 191–231. https://doi.org/10.1128/cmr.00049-16
19. Zaylaa M. Alard J. Kassaa IA. Peucelle V. Boutillier D. Desramaut J. Rosenstiel P. Nguyen HTT. Dabboussi F. Pot B. Grangette C. Autophagy: a novel mechanism involved in the anti-inflammatory abilities of probiotics. Cellular Physiology and Biochemistry. 2019; 53(5): 774-793. https://doi.org/10.33594/000000172
20. Hegar B. Waspada IM. Gunardi H. Vandenplas Y. A double-blind randomized trial showing probiotics to be ineffective in acute diarrhea in Indonesian children. The Indian Journal of Pediatrics. 2015; 82: 410-414. https://doi.org/10.1007/s12098-014-1408-5
21. Gavrilova NN. Ratnikova IA. Sadanov AK. Orasymbet SE. Shorabaev YZ. Kaptagai RZ. Selection of an active association of Probiotic bacteria and the Optimal composition of the Nutrient medium for Cultivation to increase the Therapeutic and Prophylactic effectiveness of a Medicinal probiotic preparation against Intestinal infections. Research Journal of Pharmacy and Technology. 2023; 16(5): 2427-2435. https://doi.org/10.52711/0974-360X.2023.00400
22. Indira M. Venkateswarulu TC. Chakravarthy K. Ranganadha AR. Vidya K. Prabhakar. Isolation and Characterization of Bacteriocin Producing Lactic Acid Bacteria from Diary Effluent. Research Journal of Pharmacy and Technology. Nov., 2015; 8(11): 1560-1565. https://doi.org/10.5958/0974-360X.2015.00278.4
23. Samer M. Al-Hulu. Antibacterial activity for Bacteriocin produced by Lactic acid bacteria against Clinical Bacterial Isolates. Research Journal Pharmacy and Technology. 2019; 12(9): 4205-4208. https://doi.org/10.5958/0974-360X.2019.00723.6
24. Sundaramoorthy S. Selvakumar S. Vidhya K. Antibacterial Activity of Lactobacillus Species Isolated from Dairy products against Antibiotics. Research Journal of Pharmacy and Technology. 2020; 13(8): 3915-3917. https://doi.org/10.5958/0974-360X.2020.00693.9
25. Samer M. Al-Hulu. Antibacterial activity for Bacteriocin produced by Lactic acid bacteria against Clinical Bacterial Isolates. Research Journal of Pharmacy and Technology. 2019; 12(9): 4205-4208. https://doi.org/10.5958/0974-360X.2019.00723.6
26. Hossain K. Kamrun N. Parisa S. Norhani A. Kaiser H. Mohammed FJ. Probiotic Potential of Lactic Acid Bacteria Isolated from Cheese, Yogurt and Poultry Faeces. Research Journal of Pharmacy and Technology. 2017; 10(9): 2991-2998. https://doi.org/10.5958/0974-360X.2017.00530.3
27. Gavrilova NN. Ratnikova IA. Sadanov AK. Orazymbet SE. Shorabaev EZh. Protasiuk LE. Development of Technology for the production of finished forms of Medicinal probiotics. Research Journal of Pharmacy and Technology. 2023; 16(9): 4093-4094. https://doi.org/10.52711/0974-360X.2023.00670
28. Girish YP. Rushikesh RC. Tushar NS. Jayesh SD. Suraj KI. A Short Review on Study on Different Clinical Trials Performed on Drugs before it Comes into The Market. Asian Journal of Pharmaceutical Research. 2022; 12(1): 84-87. https://doi.org/10.52711/2231-5691.2022.00013
29. Chavhan AB. Bhoi DM. Pharmacovigillance: Drug Safety Monitoring. Asian Journal of Pharmacy and Technology. 2019; 9(1): 49-52. https://doi.org/10.5958/2231-5713.2019.00009.6
30. Toscano M. de Vecchi E. Rodighiero V. Drago L. Microbiological and genetic identification of some probiotics proposed for medical use in 2011. Journal of Chemotherapy. 2013; 25(3): 156–161. https://doi.org/10.1179/1973947812y.0000000068
31. Nikam NR. Vakhariya RR. Magdum CS. Pharmacovigilance: An Overview. Asian Journal of Pharmaceutical Sciences. 2019; 9(2): 107-111. https://doi.org/10.5958/2231-5659.2019.00016.X
32. Mergentay A. Kulov DB. Bekembayeva GS. Koikov VV. Omarkulov BK. Mussabekova SA. The Analysis of Working Load of General Practitioners in the Republic of Kazakhstan. Research Journal of Pharmacy and Technology. 2019; 12(5): 2283-2288. https://doi.org/10.5958/0974-360X.2019.00381.0
33. Abhijeet S. Priyanka J. Suvidha M. Vaibhavi R. Determinatio;n, Method Development and Validation of Six Nitrosamine Impurities in Purified water by using LC-MS/MS. Asian Journal of Research in Chemistry. 2023; 16(5): 377-2. http://dx.doi.org/10.52711/0974-4150.2023.00061
34. Nguyen PQA. Yen TTH. Vinh DTT. Tien TP. Dung NA. Tu NHK. Study on the ability of producing of conjugated Linoleic acid of Lactobacillus fermentum A01 isolated from human digestive tract. Research Journal Pharmacy and Technology. 2021; 14(3): 1319-1322. https://doi.org/10.5958/0974-360X.2021.00234.1
35. Indira M. Venkateswarulu TC. Chakravarthy K. Ranganadha AR. Vidya PK. Isolation and Characterization of Bacteriocin Producing Lactic Acid Bacteria from Diary Effluent. Research Journal of Pharmacy and Technology. Nov., 2015; 8(11): 1560-1565. https://doi.org/10.5958/0974-360X.2015.00278.4
36. Sadanov AK. Gavrilova NN. Ratnikova IA. Orazymbet SE. Protasiuk LE. Massirbaeva AD. Technology for the production of Lyophilizate of an association of Lactic acid bacteria included in the Medicinal product AS-Probionorm. Research Journal of Pharmacy and Technology. 2023; 16(11): 5334-5340. https://doi.org/10.52711/0974-360X.2023.00864
37. Sahu VK. Mishra A. Sharma N. Sahu PK. Saraf SA. Physical Rheological and Cell Viability Study of Some Selected Plant Polysaccharides. Research Journal of Pharmacy and Technology. 2017; 10(1): 227-232. https://doi.org/10.5958/0974-360X.2017.00048.8